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A B  S  T R  A  C T  We have studied block of L-type calcium channels by intracellular and 
extracellular application of the ionized dihydropyridine derivatives amlodipine and 
SDZ 207-180. We find that extracellular application of either drug causes voltage- 
dependent  block  of calcium  channels.  However,  neither  drug  is  effective when 
applied intracellularly. The insensitivity of calcium channels to intracellular drug is 
not due to the low concentrations of cytosolic calcium, because voltage-dependent 
block  by  ionized  amlodipine,  SDZ  207-180,  and  the  neutral  drug  nisoldipine 
persists under conditions in which Ca  0 is buffered by EGTA. In fact, the time course 
of the development of block by the ionized but not neutral drug molecules studied, 
is slower in the presence than in the absence of calcium. Our results indicate that 
the  DHP binding  site  of the  L-type calcium channel  is  close  to  the  extracellular 
surface of the cell membrane and that ionized DHP molecules may interact with the 
receptor in a manner that is uniquely affected by calcium. 
INTRODUCTION 
Specific  1,4-dihydropyridine (DHP) ligands have been used as key molecular probes 
of L-type calcium channels and as powerful therapeutic tools to treat a wide range of 
cardiovascular  disorders  (reviewed by Janis  and Triggle,  1990).  These  compounds 
have  been  used  to  isolate  and  purify  the  channel  protein  (Flockerzi  et  al.,  1986; 
reviewed  by  Catterall,  1988;  Hosey  and  Lazdunski,  1988).  DHP's  bind  with  high 
affinity to the ~-subunit of the DHP receptor protein (Galizzi et al.,  1986;  Sharp et 
al.,  1987;  Sieber et  al.,  1987).  However,  although  the  primary structures  of rabbit 
skeletal  and  heart  muscle  DHP receptors  have been  cloned  (Tanabe  et  al.,  1987; 
Mikami et al.,  1989)  and functional activity of the L-type calcium channel  has been 
expressed (Tanabe et al.,  1988;  Mikami et al.,  1989;  Perez-Reyes et al.,  1989)  from 
the cloned cDNAs, the molecular identity and location of the DHP binding site have 
not yet been determined. 
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We  have  shown previously that  the  charged  form  of amlodipine, a  tertiary DHP 
molecule, is useful as  a  probe for the  location of the  DHP binding site  in the  cell 
membrane (Kass  and  Arena,  1989).  In  the  present  investigation we  have  used  a 
combination of charged  and  neutral  DHP  compounds  to  test  whether  the  DHP 
binding site, like that for phenylalkamines, is accessible from the inner surface of the 
cell membrane. We have determined whether block of monovalent ions, like divalent 
ions, is voltage dependent; and,  additionally, have  investigated the  dependence of 
channel block on the absence or presence of calcium. 
METHODS 
Single ventricular myocytes  were  isolated from either ventricle of adult guinea pigs using a 
method similar to that of Mitra and Morad (1985) which has been previously described (Arena 
and Kass, 1988). 
Recording methods were as described by Hamill et al. ( 1981 ) for the whole cell configuration. 
Patch pipettes were made from Gold Seal Accu-fill 90 Micropets (Clay Adams, Inc., Parsippany, 
NJ). The resistance of the pipettes was typically  1-3 MI~ when filled with 140 mM CsC1. Series 
resistance compensation was  used  in all experiments and was  adjusted  to  give  the  fastest 
possible capacity transients without producing ringing. Membrane currents were measured with 
and voltage was controlled by either a Yale Mark IV (fabricated in this laboratory from parts 
available at  New  Haven, CT) or an Axopatch  1C  (Axon Instruments, Inc., Foster City,  CA) 
voltage clamp.  Cell capacitance was  determined directly by capacity compensation of these 
circuits.  Data were sampled once every 0.3 ms and filtered at 1-2 kHz with an eight pole Bessel 
filter (Frequency Devices, Inc., Haverhill, MA). In experiments designed to dialyze  cells with 
drug-containing  solutions, pipette resistances were chosen to be < 2 MI~ and drugs were added 
to the intracellular solutions at the concentrations indicated for each experiment. 
Solutions and Drugs 
Solutions were chosen to eliminate K channel currents. Thus, the standard pipette solution 
contained in millimolar: 60 CsCI, 50 aspartic acid,  68 CsOH,  1 MgCI  2,  1 CaCl  z,  11  ethylene- 
glycol-bis-N,N,N',N'tetraacetic acid (EGTA), 5 K~TP, 10 HEPES (pH 7.4). The standard bath 
solution contained:  130 mM NaCI,  4.8 CsCI, 5 glucose,  5  HEPES  (pH  7.4).  In experiments 
designed  to  measure  divalent ion currents,  2  mM  MgClz and  divalent charge  carriers  at 
indicated concentrations  were added to the basic solution. In experiments designed to measure 
monovalent currents the following were added to the basic extracellular solution: 2 EGTA plus 
50  ~M  MgCI  2 (for  the  measurement of Na  currents)  or  2  ethylenediaminetetraacetic acid 
(EDTA) and 500 ~M MgCI  z (for the measurement of outward currents). Sodium channels were 
eliminated by  10-50  p~M  tetrodotoxin  (TTX)  (Behring  Diagnostics,  LaJolla,  CA)  and  by 
replacement of Na by N-methyl-n-glucamine  in some experiments. 
The  structures  of the  three  DHP  compounds used  in  this  study  are  shown  in  Fig.  1. 
Nisoldipine and  SDZ-207-180  were  dissolved in polyethylene glycol  400  (PEG)  to  make  a 
concentrated (1  raM)  stock  and diluted in the  bath  to  the  final concentration. PEG at  the 
concentration used (<0.01%)  has been shown to have no effects  of its  own  on Ca channel 
currents  (Kass, 1982).  Amlodipine was  dissolved in water  as  a  concentrated  (1  raM)  stock 
solution. Amlodipine concentrations were chosen as previously described (Burges et al.,  1985, 
1987;  Kass  and Arena,  1989).  SDZ-207-180  was  a  gift  of Sandoz,  Ltd.,  Basle,  Switzerland; 
nisoldipine  was a gift from Miles Laboratories, New Haven, CT; and amlodipine was a gift from 
Pfizer Central Research, Sandwich,  UK. KASS ET AL.  Block  of L-Type Ca Channels by Charged Dihydropyridines  65 
Voltage Protocols 
Membrane potential regulates  DHP modulation of/ca: block is promoted  at positive voltages 
and  relieved  at  negative voltages  (for  example,  see  Sanguinetti  and  Kass,  1984).  The  time 
course of the development or removal of block can be determined by applying a  series of test 
voltages from different holding potentials.  In the present study voltage protocols described in 
detail and illustrated in Kass and Arena (1989) were used to determine onset and recovery of 
block.  Drug  onset  was  measured  by  applying  a  depolarizing  "train"  protocol  in  which  the 
holding  potential  was  changed  from  -80  to  -40  or  -50  mV  and  test voltage pulses  were 
applied once every 5 s. Test voltages were either 0 mV (Na + currents),  + 10 mV (Ca  z+ and Ba  2+ 
currents),  or +40 to  +60 mV (Cs ÷ and K ÷ currents) and test pulse duration was 200 ms. This 
protocol was  previously shown  to maximize the onset of voltage-dependent  block by ionized 
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FIGURE  l.  Structures  of  the  three 
DHP  molecules  used  in  this  study: 
amlodipine,  nisoldipine,  and  SDZ 
207-180.  The location of the charged 
groups are indicated for pH 7.4. 
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DHP compounds  (Kass and Arena,  1989).  After development of block recovery was measured 
using train protocols in which the holding potential was changed from  -40  to  -80  mV and 
pulses were applied to the same test potentials, but test pulse duration was either 20 or 40 ms 
to minimize pulse-induced inactivation. 
In  experiments  that  required  recording  currents  from  potentials  negative  to  -60  mV, 
50-100-ms prepulses were applied to -40 mV to inactivate sodium channel and T-type calcium 
channel  currents  (Bean,  1985;  Marchetti  and  Brown,  1988).  Thus,  in  this  paper  current 
referred to as Ca channel current  (/ca) corresponds  to L-type Ca channel current according to 
the terminology suggested by Nilius et al. (1985). 
DHP Receptor: Agonism and Antagonism 
Most DHP compounds  are capable of causing enhancement or block of/Ca depending on cell 
membrane  potential  (Hess  et  al.,  1984;  Sanguinetti  et  al.,  1986;  Kass,  1987).  Binding  and 66  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  98  •  1991 
electrical  data have provided evidence that these effects are due to interactions with more than 
one binding site  (Brown et al.,  1986;  Kokubun et al.,  1986;  Wei et al.,  1986;  Williams  et al., 
1985; Hamilton et al.,  1987). The binding site probed in this study is associated with inhibition 
of channel  activity.  We rarely measured  agonistic responses  to SDZ 207-180 applied  under 
conditions  of negative  (-80  to  -100  mV)  holding potentials,  but under  similar  conditions 
observed enhancement  of currents  by amlodipine  at  pH  7.4  in  ~30%  of our experiments. 
Further  investigations will be  needed  to test whether  electrical  evidence with  charged  DHP 
derivatives can support the view that distinct binding sites exist for agonism and antagonism of 
L-channels. 
Curve  Fitting and Statistical  Procedures 
Where appropriate,  experimental  data were fitted with functions of one or two exponentials 
plus  an arbitrary baseline  using procedures  previously described  (see  Sanguinetti  and  Kass, 
1984).  All data  in  the  text  and  figures  are  means  -+  SEM.  T-tests were used  to determine 
statistical  significance between groups (Rosner,  1986).  Multiple comparisons were made using 
the pooled estimate of variance from a one-way ANOVA. 
RESULTS 
The DHP Binding Site Is Accessed from the Outside but Not the Inside  of the Cell 
To  test  for  an  intracellular  location  of the  DHP  binding  site,  we  measured  the 
sensitivity  of calcium  channel  current  to  internal  and  external  application  of the 
permanently charged drug SDZ-207-180. The charge on this compound will restrict 
it from diffusing out of the cell across the lipid membrane (Hille,  1977). As a control 
for  internal  dialysis,  we  first  measured  the  effects  of internally  applied  D890,  a 
permanently  charged  phenylalkamine  derivative  that  has  been  shown  to  block  I~:~, 
from the inside of cardiac cells (Heschler et al.,  1982; Lee and Tsien,  1984). We used 
pulse-dependent  block during train protocols to assay drug activity and, as shown in 
Fig.  2 A,  there  is  a  progressive  increase  in block as this  compound diffuses into the 
cell. In contrast, we found that SDZ 207-180 had little effect when applied internally. 
This can be seen in Fig.  2 B, which compares pulse-dependent  block after 20 min of 
dialysis with  10  I~M intracellular  SDZ  207-180 to a  3-min exposure  to 200  nM  SDZ 
207-180  applied  externally  to  the  same  cell.  We  found  a  similar  pattern  when  we 
compared intracellular with extracellular application of ionized amlodipine  (data not 
illustrated):  currents were only blocked by extracellularly  applied  drug. 
Because of the large size of isolated heart cells, we were concerned that diffusional 
exchange between the cell interior and patch pipette might be limited within the time 
frame of our experiments.  Rates  of diffusional exchange can be estimated  for heart 
cells  (Cx  ~100  pF)  by  the  methods  of  Pusch  and  Neher  (1988).  For  pipette 
resistances on the order of 3 MI) (typical for these experiments),  and for a molecular 
mass of 350 D, the diffusion time constant is  15 rain.  To confirm the insensitivity of 
Ic:a to internal application of SDZ 207-180, we compared our results obtained in heart 
cells  with  experiments  carried  out  in  GH4C1  pituitary  tumor  cells.  These  cells  are 
small  (mean  Cr =  12.65 +  1.2  pF,  N  =  12)  and  the  predicted  diffusional  time 
constant  is  40  s  (Pusch  and  Neher,  1988).  For these  cells,  we found that  internally 
applied  D890  (100  IxM)  completely  blocked  lea,  consistent  with  the  predictions  of 
Pusch and  Neher.  However,  as was  the  case  for heart  cells,  Ic, was  not  blocked by KASS ET AL.  Block of L-Type  Ca Channels by Charged Dihydropyridines  67 
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FIGURE 2.  Effects of internal and external application of quaternary Ca channel blockers in 
heart  cells.  Currents were  measured  during the  application of onset  train protocols  with 
permanently charged drugs added to the whole-cell patch pipettes. (A) D890 (100  i~M) was 
included in the pipette. Currents were measured during onset trains applied 5, 10, and 15 rain 
after establishing  whole-cell recording conditions. Currents at start of each train were 954, 871, 
and 754 pA, respectively. Cell 26081. Charge carrier: 2 mM Ca.  (B) SDZ 207-180 was (1  I,M) 
added  to  pipette  and  no pulse-dependent block developed. The  solid circles  are  currents 
measured during an onset train applied 23  rain after establishing whole-cell conditions. The 
cell was  then exposed  to  an external solution containing 200  nM SDZ  207-180. The solid 
triangles are  currents recorded  in response  to  the  same  onset train protocol  3  min after 
changing to this external solution. Cell 11081. 68 
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FIGURE 3.  Block  of  barium 
currents  in a  GH4C ] cell by ex- 
ternal  and  not  internal  SDZ 
207-180.  Currents  measured 
from a  -30  mV holding poten- 
tial  in  10  mV  intervals  from 
-40  to  +50  mV are shown be- 
fore (circles) and after (triangles) 
applying  onset  train  protocols. 
The  patch  pipette  contained 
500 nM SDZ 207-180.  (A) Cur- 
rents  recorded  immediately 
(circle) and 3 rain after (triangle) 
establishing  whole-cell  condi- 
tions.  (B)  Currents  recorded  5 
min  after  establishing  whole- 
cell  conditions  before  (circle) 
and after (triangle)  exposing the 
cell  to  500  nM  externally  ap- 
plied SDZ 207-180.  [Ba]0  =  50 
mM.  Calibration  bars:  200  pA, 
15 ms. Cell 98895. 
internal  SDZ  207-180  in  GH4C 1 cells,  but was  blocked  by external  drug  application 
(Fig.  3).  Fig.  4  summarizes  the  results  for  internal  vs.  external  application  of the 
quaternary  DHP  for both  types of cells. 
These experiments  provide evidence that ionized drug access of the DHP receptor 
is  not  via  the  inner  surface  of the  cell  membrane.  However,  because  intracellular 
calcium  is  buffered  to  submicromolar  levels  in  our  experiments  (Methods),  it  is 
possible  that  the  charged  DHP  molecule  is  not  an  effective  blocker  under  these 
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FIGURE 4.  Block  of  calcium 
channel  currents  by  external, 
but not internal,  application  of 
SDZ  207-180  in  heart  and 
GH4C n cells.  The  bars  summa- 
rize  the  mean  current  blocked 
by internal  and  external  appli- 
cation of SDZ 207-180  in heart 
(open  bars)  and  GH4C  cells 
(shaded  bars).  Internal  concen- 
trations were  1-10 ~M in heart 
(n =  6)  and  500  nM  in  GH4C 1 
cells  (n =  9).  External  concen- 
trations  were  200  nM  in  heart 
(n =  7) and  500 nM for GH4C ] 
cells  (n =  8).  (*)  Significantly 
greater  than  internal  applica- 
tion P  _<  0.005. KASS Err AL.  Block of L-Type Ca Channels by Charged Dihydropyridines  69 
conditions. We tested for this possibility by measuring the influence of calcium on the 
voltage dependence of SDZ 207-180 block. 
Influence of Calcium on DHP Block and Recovery:  Contrast  between Neutral and 
Charged Drugs 
Fig. 5 shows examples of experiments in which SDZ 207-180 block was studied under 
conditions in which calcium carried the charge and in which Ca  0 was buffered and Na 
or Cs were the charge carriers. Records are shown in the absence of drug, and during 
the  onset of SDZ  207-180  block of currents. This compound blocks  in a  voltage- 
dependent manner when calcium is the charge carrier, and when Ca  0 is buffered and 
Ca +2  Na + 
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FIGURE 5.  Influence of calcium on voltage-dependent block by SDZ 207-180. Current traces 
illustrate Ca, Na, and Cs ions carrying the charge during onset train protocols in the presence 
of 200 nM SDZ 207-180. Traces are shown at the start of the train protocol, 50 s, and 100 s 
after  applying pulses  (Na,  Cs),  and  100  and  200  s  after  starting  the  onset  train  (Ca). 
Monovalent currents were measured in the presence of EGTA and EDTA (Methods).  The plot 
shows normalized currents measured in the absence (open symbols) and presence (solid symbols) of 
200 nM SDZ 207-180 as a function of time after start of the train protocol. The permeant ions 
were Ca (squares), Cs (circles), and Na (triangles). The tonic block at start of train protocols for 
each charge carrier was 13% (Ca), 0% (Na), and 14% (Cs). Calibration bars: 18 ms; 400 pA (Ca), 
1.3 nA (Na), and 3.14 nA (Cs). Cells:  11391  (Ca);  111491  (Na); 22AG94 (Cs). 70  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  98.  1991 
Cs ÷ or Na + carry the charge.  Interestingly, the development of block is faster when 
Ca0  is  chelated  by  EGTA.  Similar results were  obtained with  ionized amlodipine. 
Thus,  the  ineffectiveness of internally applied SDZ  207-180 and amlodipine is  not 
due to the low concentration of calcium in our intracellular solutions. 
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FIGURE 6.  Voltage-dependent block by nisoldipine in the absence and presence of calcium. 
Currents were measured in the absence (open) and presence of 50 nM nisoldipine (solid) at 0 mV 
(triangles) and +60 mV (circles) during onset train procedures in the same cell (103194).  Traces 
show currents in response to the first, tenth, and last pulse in each train. The external solution 
contained 50  I~M Mg  +z,  and 2 mM EGTA.  Pulses were applied at 5  s/pulse as described in 
Methods. Calcium currents measured in response to the same protocol but with V,e~, =  + 10 mV 
are  plotted  as  solid  squares.  The  Ca  data  were  obtained from  cell  7J82.  Currents were 
normalized to the maximum current at the beginning of each train. These current amplitudes 
were:  5.3 nA (control, Na),  5.01  nA (drug, Na),  3.14 nA (drug, Cs), 813 pA (control, Ca), and 
840 pA (drug, Ca). 
Neutral Drugs: Nisoldipine 
Do neutral and charged DHP compounds share a common sensitivity to conditions in 
which  Ca0  is  chelated?  We  investigated  the  influence  of  Ca0  on  the  voltage- 
dependence of block by the neutral DHP nisoldipine to test this possibility and the KASS ET AL.  Block  of L-Type Ca Channels by Charged Dihydropyridines  71 
results are presented in Fig. 6.  Under conditions in which Ca0 is chelated, block of 
monovalent currents  by nisoldipine  is voltage-dependent,  and  the  time  course  of 
block onset is affected neither by the marked difference in test pulse voltage nor in 
the  ionic  species  carrying  the  charge.  However,  in  contrast  to  the  actions  of the 
ionized  molecules,  the  onset  of nisoldipine  block  is  unchanged when  Ca0  is  not 
buffered and calcium is the charge carrier. 
DISCUSSION 
The  major  new  result  presented  in  this  paper  is  that  the  permanently  charged 
compound  SDZ  207-180  and  ionized  amlodipine  are  much  more  potent  when 
applied extracellularly compared with intracellular application. In addition, we find 
that  the  development  of voltage-dependent  block  by  ionized  and  neutral  DHP 
molecules persists under conditions when calcium is buffered to micromolar concen- 
trations, but that the onset of block by the two ionized drugs is slower in the presence 
than in the absence of calcium. 
Extracellular  Access to the DHP Binding Site 
Our experiments in which we compared intracellular and extracellular application of 
ionized amlodipine and SDZ 207-180 in heart and GH4C1 cells provide evidence that 
these two charged DHP compounds cannot reach the DHP receptor via an intracel- 
lular  pathway.  This  finding  contrasts  with  the  accessibility  of  the  permanently 
charged drug D890 to the phenylalkamine receptor which occurs via an intracellular 
pathway in guinea pig ventricular cells (Heschler et al.,  1982),  but not in vascular 
smooth muscle cells of the rabbit (Leblanc and Hume, 1989).  Our result is, however, 
consistent with data reported by Iijima et al. (1984) for intracellular application of the 
DHP nicardipine. The difference in intracellular accessibility of the two permanently 
charged drug types supports the view that the binding sites for DHPs and phenyl- 
alkamines on  the  ~l-subunit  of the  DHP  receptor  protein  are  physically separate 
entities (Glossmann et al.,  1984). 
Location  of the DHP Binding Site 
Valdivia and Coronado (1990)  have reported that SDZ  207-180  can interact with a 
high affinity DHP binding site when applied to either side of a  planar lipid bilayer 
into which  skeletal  muscle  transverse  tubule  Ca  channels  had  been  incorporated. 
They suggested that the  10 methylene groups that separate the quaternary ammo- 
nium from the DHP ring in this molecule (Fig.  1) are sufficiently long to allow the 
DHP  moiety to be  uncharged and reach  the  DHP binding site through the  lipid 
bilayer regardless of the side of application. If this view is correct, then our results, 
which show an asymmetrical response in both intact heart and GH4C J cells, suggest 
that the high affinity DHP binding site is closer to the extracellular membrane face 
than the intracellular face and is just beyond the reach of the methylene spacer chain 
when  applied  from  the  intracellular  side  of  the  membrane.  These  results  are 
consistent with conclusions reached from investigations of the sensitivity amlodipine 
to changes in external hydrogen ion concentrations (Kass and Arena,  1989). 72  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  98.  1991 
Calcium Ions Modify Block by Ionized DHP Derivatives 
Our results cannot be explained by a change in blocking activity of SDZ 207-180 due 
to the low levels of intracellular calcium because we find that voltage dependence of 
block by neutral and ionized DHP molecules is preserved under conditions in which 
calcium is buffered to micromolar concentrations by either EGTA or EDTA (see also 
Hess  et  al.,  1986;  Hadley and  Hume,  1987).  However,  under  conditions  in which 
calcium is the permeant ion, block by ionized amlodipine and SDZ 207-180 develops 
at a  slower rate  than  under  conditions  when  Ca0  is  buffered  and  monovalent  ions 
carry  the  charge.  Block  by  the  neutral  molecule  nisoldipine  is  not  affected  by 
chelating Ca0. Recovery from block by these two ionized DHPs, but not nisoldipine, is 
also slower when calcium is the charge carrier (data not shown). 
These  results  are  similar  to  those  of Carbone  and  Lux  (1988a,  b,  1989)  who 
reported  that  t0-Conotoxin  (¢o-CTX)  blockade  of high  threshold  (L-type)  calcium 
channels  differed markedly depending  on the  type of ion carrying charge  through 
the open channel pore. Those authors suggested that 00-CTX binding was influenced 
by  charge  carrier-induced  channel  conformational  changes.  Permeating  charge 
species-induced  differences  in  channel  conformation  are  expected  since  channel 
permeation  is  determined  by  two  intrapore  binding  sites  with  varying  affinity  for 
monovalent and  divalent ions  (Almers and  McCleskey,  1984;  Hess et al.,  1986).  In 
fact,  Prod'hom  et  al.  (1989)  have  reported  that  charge  carrier-induced  conforma- 
tional changes underlie  the modulation of proton-induced fluctuations in L-channel 
conductance  levels,  and  suggested  that  Ca  forms  a  stabilizing  complex  with  the 
calcium channel  protein  and  limits the  flexibility of the channel  protein  that  exists 
when  other  ion  species  permeate  the  channel.  Our  results  are  consistent with  this 
view  of the  channel,  but  cannot  rule  out  the  possibility  that  it  is  an  interaction 
between the charged head groups of amlodipine or SDZ 207-180 with extracellular 
calcium that interacts with the drug-bound state of the channel.  Future experiments 
with other ionized drug molecules will be useful in distinguishing  these possibilities. 
SUMMARY 
In summary, our results have shown that charged DHP derivatives are very useful as 
probes of the L-type channel  in intact cell membranes. We have found that ionized 
amlodipine  and  the  permanently  charged  derivative  SDZ  207-180  are  useful  in 
determining  the location of the  DHP binding  site that causes inhibition  of channel 
activity. Studies  of other DHP derivatives with different charge locations will further 
define  the  location  of this  site  and  provide  insight  into  possible  conformational 
changes L-channels undergo for varied permeant ions. 
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